PAVmed  logo
PAVmed PAVM
$ 1.01 -1.94%

Quarterly report 2024-Q2
added 08-12-2024

report update icon

PAVmed Income Statement 2011-2024 | PAVM

Annual Income Statement PAVmed

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

16 M 13.1 M 155 M 97.2 M 44.4 M 22.1 M 24.7 M 76.3 M - - - - -

Shares

7.23 M 5.94 M 77.5 M 47.4 M 30.2 M 22.3 M 13.5 M 13 M - - - - -

Historical Prices

2.21 2.21 2.46 2.12 1.2 0.962 2.29 6.9 - - - - -

Net Income

-64.2 M -89 M -50.3 M -34.3 M -16.5 M -18 M -9.52 M -5.65 M -1.78 M - - - -

Revenue

2.5 M 377 K 500 K - - - - - - - - - -

Cost of Revenue

6.42 M 3.61 M 585 K - - - - - - - - - -

Gross Profit

- - -85 K - - - - - - - - - -

Operating Income

-68.8 M -91.1 M -54.4 M -23.4 M -14.3 M -10.6 M -8.03 M -5.65 M - - - - -

Interest Expense

-10.5 M -12.2 M -1.73 M -12.5 M -2.97 M 2.39 M 725 K - - - - - -

EBITDA

-65.9 M -88.6 M -54.3 M -24 M -14.3 M -10.6 M -8.03 M -5.65 M -1.78 M - - - -

Operating Expenses

- - 54.3 M - 14.3 M 10.6 M 8.03 M 5.65 M - - - - -

General and Administrative Expenses

30.9 M 41.4 M 25.6 M 12.4 M 7.66 M 6.31 M 5.42 M 3.93 M 1.29 M - - - -

All numbers in USD currency

Quarterly Income Statement PAVmed

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

9.15 M 8.69 M 8.58 M 112 M 6.96 M 6.47 M 94.5 M 89.8 M 87 M 86.3 M 86.4 M 83.3 M 82.2 M 74 M 63.8 M 48.4 M 44.8 M 43.5 M 40.5 M 31 M 27.6 M 27.1 M 27.1 M 26.5 M 19.3 M 16.5 M 14.6 M 13.3 M 13.3 M 13.3 M 13.3 M 13.3 M 13 M 12.2 M 12.2 M 11.1 M 10.9 M 10.9 M - - - - - - - - - - - - - - - -

Net Income

-10.8 M -15.2 M - -17.7 M -14.5 M -17.9 M - -26.1 M -25.5 M -16.9 M - -12.2 M -11.5 M -9.43 M - -5.48 M -5.58 M -14.5 M - -3.08 M -3.59 M -3.54 M - -3.25 M -5.07 M -2.83 M - -5.13 M -990 K -9.52 M -1.71 M -1.93 M -1.31 M -697 K -731 K -539 K -361 K -146 K - - - - - - - - - - - - - - - -

Revenue

1 M 1 M - 791 K 166 K 446 K - 76 K 189 K 189 K - 200 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

1.67 M 1.74 M - 1.78 M 1.68 M 1.35 M - 1.63 M 369 K 369 K - 144 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - -180 K -180 K - 56 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-13.7 M -14 M - -15.5 M -16.5 M -20.4 M - -23.4 M -23.5 M -19.6 M - -13.7 M -13 M -8.08 M - -5.53 M -5.01 M -5.25 M - -3.24 M -3.32 M -3.14 M - -2.57 M -2.74 M -1.94 M - -1.97 M -2.02 M -2.16 M - -1.93 M -1.31 M -697 K - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - - -6.22 M -1.41 M -1.81 M - -6.56 M -5.62 M 2 K - -1.73 M 300 K -2.03 M - -346 K -830 K 52.5 K - -28 K -420 K -560 K - 708 K 500 K 500 K - 362 K 1.03 M 2.11 M - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-13.6 M -13.4 M - -15 M -16 M -19.7 M - -22.9 M -22.8 M -19.4 M - -13.6 M -12.9 M -8.06 M - -5.51 M -5 M -5.25 M - -3.23 M -3.32 M -3.14 M - -2.57 M -2.74 M -1.94 M - -1.96 M -2.02 M -2.15 M - -1.93 M -1.31 M -697 K - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - 23.5 M 19.3 M - 13.7 M 13 M 8.08 M - 5.53 M 5.01 M 5.25 M - 3.24 M 3.32 M 3.14 M - 2.57 M 2.74 M 1.94 M - 1.97 M 2.02 M 2.16 M 1.71 M 1.93 M 1.31 M 697 K 731 K 539 K 361 K 146 K - - - - - - - - - - - - - - - -

General and Administrative Expenses

7.01 M 6.68 M - 6.86 M 6.65 M 10.4 M - 10.4 M 11.2 M 9.48 M - 6.11 M 6.84 M 3.38 M - 2.22 M 2.42 M 2.24 M - 1.72 M 1.91 M 1.69 M - 1.4 M 1.59 M 1.38 M - 1.26 M 1.32 M 1.5 M 1.1 M 1.35 M 960 K 518 K 589 K 274 K 293 K 130 K - - - - - - - - - - - - - - - -

All numbers in USD currency